drugset / Trial / NCT06454825

Effects of Antiemetic Agents in Orthognathic Surgery Patients

NCT06454825 ↗

Phase 4 Completed 66 enrolled Bezmialem Vakif University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

In an effort to prevent or treat consistently high rates of PONV following maxillofacial operations, several medications, techniques and multimodal protocols have been studied. In the present study, the investigators hypothesized that combining metoclopramide with granisetron will improve PONV incidence when compared with granisetrone alone.

Timeline

Start
2020-04-14
Primary completion
2021-04-05
Completion
2021-04-05

Outcome

Met primary endpoint

paper PONV scores at the second hour were 1.56 ± 1.45 in group G and 0.79 ± 0.90 in group GM (P = .03). PMID 39824505 ↗

paper Compared to granisetron alone, the combination of granisetron and metoclopramide was associated with significant PONV control PMID 39824505 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified 3 mg Intravenous
Subject Intravenous drug Unknown 10 mg Intravenous